Biosimilars - On Demand Webinar
Join Jashin Wu, MD as he presents on biosimimlars: considerations for psoriatic diseases. Topics of this webinar include, the mechanism of action, routes of adminstration, and dosage of biosimilar drugs used in psoriatic disease, current legislation and FDA procedures related to biosimilar approvals and prescriptions, and how to identify manufacturing facility standards and procedures that contribute to variations among biosimilar drugs and biologies.
To view the on-demand webinar for CME credit, please login and select Take Course at right.
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Psoriasis Foundation designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Dermatologists, rheumatologists, primary care physicians, and allied health providers
- Describe the mechanism of action, routes of administration and dosage of biosimilar drugs used in psoriatic disease in relation to the reference products.
- Describe current legislation and FDA procedures related to biosimilar approvals and prescriptions, and implement tools and strategies when faced with interchangeability challenges from pharmacies or insurers, including notification, documentation and prevention.
- Identify manufacturing facility standards and procedures that contribute to variations among biosimilar drugs and biologics and articulate how these procedures create molecules that are similar to, but not replications of the original molecule, and how generic drugs differ from biosimilars.
Questions? Contact us at email@example.com or 503-546-8387